Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice

This publication has 29 references indexed in Scilit:

• A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery
  Vaccine, 2000
• Carbohydrate Biopolymers Enhance Antibody Responses to Mucosally Delivered Vaccine Antigens
  Infection and Immunity, 2000
• Chitosans as absorption enhancers of poorly absorbable drugs
  European Journal of Pharmaceutical Sciences, 1999
• Stimulation of mucosal and systemic antibody responses against Bordetella pertussis filamentous haemagglutinin and recombinant pertussis toxin after nasal administration with chitosan in mice
  Vaccine, 1998
• Chitosan: A Unique Polysaccharide for Drug Delivery
  Drug Development and Industrial Pharmacy, 1998
• Chitosans as Absorption Enhancers for Poorly Absorbable Drugs 2: Mechanism of Absorption Enhancement
  Pharmaceutical Research, 1997
• The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro
  Journal of Controlled Release, 1996
• Chitosan as a nasal delivery system: evaluation of insulin absorption enhancement and effect on nasal membrane integrity using rat models
  European Journal of Pharmaceutical Sciences, 1996
• Chitosans as Absorption Enhancers for Poorly Absorbable Drugs. 1: Influence of Molecular Weight and Degree of Acetylation on Drug Transport Across Human Intestinal Epithelial (Caco-2) Cells
  Pharmaceutical Research, 1996
• Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
  Pharmaceutical Research, 1994